Crucell Gets Wyeth Orders

The orders will start benefiting its business in 2007.
Author:
Publish date:

Vaccine maker

Crucell

(CRXL)

said it received its first contract manufacturing orders from

Wyeth's

(WYE)

biotech group.

Crucell expects the orders to start benefiting its business in 2007.

Shares of Crucell gained 40 cents, or 1.6%, to $25.06.